4//SEC Filing
Sham Hing 4
Accession 0000899243-18-001372
CIK 0001629137other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 7:51 PM ET
Size
9.5 KB
Accession
0000899243-18-001372
Insider Transaction Report
Form 4
Sham Hing
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2018-01-16+1,600→ 83,104 total - Exercise/Conversion
Restricted Stock Units
2018-01-16−1,600→ 10,400 total→ Common Stock (1,600 underlying) - Tax Payment
Common Stock
2018-01-16$52.10/sh−703$36,626→ 82,401 total
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer's Common Stock.
- [F2]Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 1,600 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]On August 11, 2017, the Reporting Person was granted 12,000 RSUs, which vest in installments upon the achievement of specified market capitalization milestones of the Issuer on or before December 31, 2019, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting milestone. On January 16, 2018, one of the performance milestones was achieved, resulting in the vesting of 1,600 shares of Common Stock underlying the RSU grant. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001650158
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 7:51 PM ET
- Size
- 9.5 KB